Sonavex raises $15M to support novel ultrasound solutions
Sonavex closed a $15 million Series A-2 financing round to support its ultrasound technologies.The Baltimore, Maryland-based Johns Hopkins spinout develops the EchoMark and EchoSure...
Okami Medical closes $32.5M financing to support catheter tech for peripheral vascular occlusion
Okami Medical announced it closed a $32.5 million financing round to support its catheter-based technologies.Aliso Viejo, California-based Okami develops multiple technologies for peripheral vascular...
Diagnostics company Cirdan secured a £7.5m investment
Lisburn-based medical imaging company Cirdan has raised £7.5 million (€8.9 million) from a pair of investors in a funding round it says will help...
Horizon Surgical Systems raises $30 million in Series A financing
Horizon Surgical Systems, Inc., a privately-held, micro-robotics company advancing microsurgery with automated AI-enabled robotics, announced the close of a $30M Series A financing. The...
Rivermark Medical closes $30 million Series C financing to advance FloStent™ system for benign prostatic hyperplasia
Rivermark Medical, a leader in minimally invasive solutions for Benign Prostatic Hyperplasia (BPH), closed a $30 million Series C financing round. The round was...
Siloton secures £860k to advance eye imaging chip for AMD
UK-based eye health start-up Siloton has scored £860,000 in additional funding to drive to market its optical coherence tomography (OCT) chip technology designed to...
ShiraTronics raises $66M to support implantable migraine therapy
ShiraTronics closed a $66 million Series B financing round to support its Migraine Therapy System. The Minneapolis-based company designed its minimally invasive implantable neuromodulation...
MONCYTE Health raises €1M to advance personalised treatment for high cholesterol
MONCYTE Health has announced the closure of a 1 million EUR seed round to fund its go-to-market strategy. The company's technology is designed to...
Nyxoah raises $27M for sleep apnea neuromod
Nyxoah sold 3 million shares to raise $27 million in gross proceeds to support its sleep apnea therapy. Mont-Saint-Guibert, Belgium–based Nyxoah develops neuromodulation technology...